Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xue Jie, also known as Dragon's Blood or Sanguis Draconis, is a traditional Chinese medicine (TCM) ingredient derived from the reddish resin of certain plants, primarily from the Daemonorops genus (e.g., Daemonorops draco). It is traditionally used to invigorate blood circulation, dispel blood stasis, alleviate pain, stop bleeding, and promote tissue regeneration. It is often applied topically for wound healing and internally for conditions related to blood stasis, such as traumatic injuries, abdominal pain, and gynecological issues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xue Jie.